Literature DB >> 3801976

Retinal angiomatosis: the ocular manifestations of von Hippel-Lindau disease.

M Ridley, J Green, G Johnson.   

Abstract

The ocular manifestations of a large von Hippel-Lindau pedigree are presented. Of 24 persons with retinal angiomas, 18 are living and are the basis of this report. Nineteen of their 28 affected eyes were asymptomatic with 2 to 4 small tumours per eye. Nine eyes had lost vision secondary to exudative detachment. Seven of these had peripheral disease with rapid recurrences. Two had untreated disc tumours. Tumours less than 1 disc diameter (DD) in size were easily treated with photocoagulation. Multiple treatments of cryotherapy were required for larger tumours. Scleral buckle and early vitrectomy are recommended for vitreous traction. Tumour in a 4-year-old and a de-novo tumour in a 42-year-old lead us to recommend life-time surveillance of patients at risk. Many patients had false negative family histories. A review of the literature leads us to suspect that the majority of retinal angiomas are familial. We emphasize the ophthalmologist's responsibility to investigate such patients.

Entities:  

Mesh:

Year:  1986        PMID: 3801976

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  15 in total

1.  Total exudative detachment as a first presentation of von Hippel Lindau disease.

Authors:  A Ferguson; J Singh
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

Review 2.  Von Hippel-Lindau disease.

Authors:  E R Maher; A T Moore
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

Review 3.  [Capillary hemangioma of the retina in cases of von Hippel-Lindau syndrome. New therapeutic directions].

Authors:  N Bornfeld; K-M Kreusel
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

4.  Discrimination between normal and glaucomatous eyes with visual field and scanning laser polarimetry measurements.

Authors:  R Lauande-Pimentel; R A Carvalho; H C Oliveira; D C Gonçalves; L M Silva; V P Costa
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

5.  Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.

Authors:  Emily Ying Chew
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 6.  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.

Authors:  Klaus-Martin Kreusel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

7.  Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.

Authors:  Roseline Vibert; Khadija Lahlou-Laforêt; Maryam Samadi; Valérie Krivosic; Thomas Blanc; Laurence Amar; Nelly Burnichon; Caroline Abadie; Stéphane Richard; Anne-Paule Gimenez-Roqueplo
Journal:  Eur J Hum Genet       Date:  2022-08-02       Impact factor: 5.351

8.  Von Hippel Lindau disease: keep it in the family.

Authors:  Michael Adly Mikhail; Jia Ng; Joseph Mathew; Zachariah Koshy
Journal:  BMJ Case Rep       Date:  2012-12-14

9.  A case of von Hippel-Lindau disease with juxtapapillary retinal capillary hemangioma and nutcracker phenomenon.

Authors:  Güliz Fatma Yavaş; Nazan Okur; Tuncay Küsbeci; Esma Norman; Ümit Inan
Journal:  Int Ophthalmol       Date:  2012-11-01       Impact factor: 2.031

10.  Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma.

Authors:  Aniruddha Agarwal; Neha Kumari; Ramandeep Singh
Journal:  Int Ophthalmol       Date:  2016-01-27       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.